Department of Surgical Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Indian J Cancer. 2022 Jan-Mar;59(1):115-118. doi: 10.4103/ijc.IJC_608_20.
Langerhans cell histiocytosis (LCH) is a rare monoclonal disease of antigen presenting cells. Involvement of thyroid gland by LCH is exceedingly rare. Herein, we present a case of LCH involving the thyroid in a 38-year-old woman. Our patient presented clinically as a case of primary thyroid neoplasm. Presence of elongated, epithelioid neoplastic cells with grooved nuclei along with presence of background eosinophils were seen on fine-needle aspiration cytology (FNAC) and histopathology. Positive staining for CD1a and S100 immunohistochemistry confirmed the diagnosis of LCH. Patient was given combination chemotherapy and has responded well to the same without any complaints for last 6 months. With this report, our goal is to expand awareness of this rare tumor in the thyroid. Consideration at the time of FNAC and its correct diagnosis on subsequent excision is imperative for patient management.
朗格汉斯细胞组织细胞增生症(LCH)是一种罕见的抗原提呈细胞单克隆疾病。LCH 累及甲状腺极其罕见。本文报道了一例 38 岁女性 LCH 累及甲状腺的病例。我们的患者临床上表现为原发性甲状腺肿瘤。细针穿刺细胞学(FNAC)和组织病理学检查可见细长的上皮样肿瘤细胞,核呈沟状,伴有背景嗜酸性粒细胞。CD1a 和 S100 免疫组化阳性染色证实了 LCH 的诊断。患者接受了联合化疗,且在过去 6 个月内无任何不适,反应良好。通过本报告,我们旨在提高对甲状腺这种罕见肿瘤的认识。在 FNAC 时考虑到这一点,并在随后的切除时正确诊断,对患者的管理至关重要。